Analyst Price Target is $22.75
▲ +636.25% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Ocuphire Pharma in the last 3 months. The average price target is $22.75, with a high forecast of $26.00 and a low forecast of $20.00. The average price target represents a 636.25% upside from the last price of $3.09.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in Ocuphire Pharma.